Host gut environment and immune system

The host gut environment and immune system represent a complex, integrated ecosystem comprising the intestinal microbiota, the epithelial barrier, and the gut-associated lymphoid tissue (GALT) (Mowat & Agace, 2014, Nature Reviews Immunology). This system is responsible for maintaining homeostatic balance by distinguishing between commensal microorganisms and potential pathogens while facilitating nutrient absorption and metabolic functions (Belkaid & Hand, 2014, Cell). Dysregulation of this axis is a hallmark of various pathologies, including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and systemic autoimmune conditions (Xavier & Podolsky, 2007, Nature). Therapeutic interventions often aim to modulate this environment through probiotics, fecal transplants, or targeted biologics that inhibit specific inflammatory pathways or leukocyte recruitment to the intestinal mucosa (Danese et al., 2015, Gut). For instance, vedolizumab specifically targets the α4β7 integrin to prevent T-cell homing to the gut, thereby reducing inflammation without systemic immunosuppression (Feagan et al., 2013, NEJM). Understanding the bidirectional communication between the gut microbiome and the host immune system is critical for developing precision medicines for gastrointestinal and systemic inflammatory disorders (Khanna et al., 2017, Therapeutic Advances in Gastroenterology).

Other names

Gut-immune axisIntestinal mucosal immune systemGastrointestinal immune systemGut-associated lymphoid tissue (GALT)Microbiota-immune axis

Therapeutic modulation involves the suppression of pro-inflammatory signaling pathways, the blockade of site-specific leukocyte trafficking, and the restoration of microbial diversity to maintain the intestinal barrier and immune homeostasis.